. Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity. J Neurol. 2025 Mar 6;272(3):254. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.